GSK and Eli Lilly are the latest multinational drugmakers to unveil plans to build more U.S. manufacturing plants and other operations, moves aimed partly at mitigating the threat of tariffs
葛兰素史克(US:GSK) WSJ·2025-09-17 00:00公司动态 - GSK和礼来公司宣布在美国增加制造业务计划 [1] - 两家公司计划扩大在美国的其他运营活动 [1] 行业趋势 - 制药行业近期出现多家企业在美国扩大生产规模的现象 [1]